Born at the tail end of the legendary commodities bull market of the 1970s, Luke Burgess is one of a new generation of investors who have become fascinated with the intrinsic and universal value of gold and the junior company's that chase the yellow metal.
He believes that the underlying fundamentals that pushed gold to record highs in 1980 are this time significantly magnified. Luke says, "The US dollar is in major bear market, the Government debt levels are completely unsustainable, and the geopolitical front looks tenuous at best. Meanwhile, investment demand for gold is skyrocketing while new supplies from old mines are falling fast. Gold prices are coiled to skyrocket."
But Luke is more than just a worshipper of the yellow metal. He holds investments in other metals including silver, platinum, palladium, copper, zinc, molybdenum and is also a large investor in other tangible natural resource commodities including oil, natural gas, land, and even foods.
Professionally, Luke is the managing editor of Hard Money Millionaire, a high-end investment advisory service that delivered subscribers 22 winning investments out of 23 recommendations in 2009. At its best, his 2009 portfolio returned members seven (7) winning investments that each returned a +100% gain. In fact, the gains from his Hard Money Millionaire portfolio are on par with $100 million hedge funds! For the year, the Hard Money Millionaire portfolio returned an average of 21.3%. Meanwhile, hedge funds returned an average of 24.1% for 2009.
Luke is also a weekly contributor to Wealth Daily and has had his articles published at other investment sites like StockHouse, Seeking Alpha, and Goldseek. He has additionally been a featured guest on countless radio programs including Trader's Nation, The Bill Meyer Show, Sound Investing Radio, The Brent Clanton Show, Stock Doctor, The Economic Contrarian, On the Money, The Andre Eggelation Show, KXYZ Biz Radio, and Investments Advisor Review.
Where do 6,723 brokers & analysts turn to for investment ideas?
The Wealth Daily e-Letter
Skip the middleman--and get them here first...
Big Pharma's Survival Strategy
$7.5 billion a year in research and development is simply too big a pill for Big Pharma to swallow.
That's why they're buying out their breakthroughs for pennies on the dollar.
And their biggest target right now... is one I'm guaranteeing with my own money.